TMDX TransMedics Group, Inc.
$88.58
TransMedics Group, Inc. (TMDX) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is $0.32 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +22.5% since its last earnings release on August 4, 2026.
TransMedics Group Missed Consensus Estimates, Narrows Guidance
Tuesday, August 4, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs $0.32
Rev est $178.66M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$83.14
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.
Sector
Healthcare
Industry
Medical Appliances/Equipment